ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

PDSB PDS Biotechnology Corporation

3.89
0.16 (4.29%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
PDS Biotechnology Corporation PDSB 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.16 4.29% 3.89 09:00:00
개장가 저가 고가 종가 전일 종가
3.85 3.74 3.96 3.82 3.73
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/01/202406:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202406:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/01/202407:10EDGAR2Form 8-K - Current report
23/01/202406:45GLOBEPDS Biotech Announces Retirement of Lauren V. Wood, M.D.,..
16/01/202422:00GLOBEPDS Biotech to Participate at B. Riley Securities 4th Annual..
05/12/202306:50GLOBEPDS Biotechnology Reports Inducement Grant Under Nasdaq..
05/12/202306:02EDGAR2Form 8-K - Current report
28/11/202321:30GLOBEPDS Biotech Appoints Lars Boesgaard as Chief Financial..
28/11/202320:02EDGAR2Form 8-K - Current report
14/11/202321:30GLOBEPDS Biotech Reports Third Quarter 2023 Financial Results and..
10/11/202306:07EDGAR2Form 8-K - Current report
09/11/202322:00GLOBEPDS Biotech Announces Updated Survival Data from NCI-Led..
07/11/202322:00GLOBEPDS Biotechnology Announces Conference Call and Webcast for..
24/10/202305:06EDGAR2Form 8-K - Current report
23/10/202321:00GLOBEPDS Biotech Announces Preliminary Biomarker Study Results in..
12/10/202305:02EDGAR2Form 8-K - Current report
11/10/202321:00GLOBEPDS Biotech Announces Interim Safety and Immune Response..
04/10/202305:03EDGAR2Form 8-K - Current report
04/10/202305:03EDGAR2Form 8-K - Current report
03/10/202322:02EDGAR2Form 8-K - Current report
03/10/202320:00GLOBEPDS Biotech Announces Interim 24-Month Survival Rate of 74%..
03/10/202305:05EDGAR2Form 8-K - Current report
02/10/202321:00GLOBEPDS Biotech Announces PDS0101 Combined with..
26/09/202321:00GLOBEPDS Biotech to Present at the LD Micro Main Event XVI
25/09/202321:00GLOBEPDS Biotech Reschedules Key Opinion Leader Roundtable..
21/09/202305:10EDGAR2Form 8-K - Current report
21/09/202305:05GLOBEPDS Biotech to Participate in the 2023 Cantor Fitzgerald..
20/09/202321:00GLOBEPDS Biotech Announces PDS0202 Elicits Active Neutralization..
13/09/202321:00GLOBEPDS Biotech to Host Key Opinion Leader Roundtable Addressing..
12/09/202305:05EDGAR2Form 8-K - Current report
08/09/202319:02EDGAR2Form 8-K - Current report
07/09/202305:05GLOBEPDS Biotech to Participate at the H.C. Wainwright 25th..
06/09/202321:00GLOBEPDS0202 Universal Influenza Preclinical Ferret Data to be..
19/08/202305:04EDGAR2Form 8-K - Current report
18/08/202305:05EDGAR2Form 8-K - Current report
16/08/202321:00GLOBEPDS Biotech Announces Data from IMMUNOCERV Phase 2 Trial..
15/08/202305:05EDGAR2Form 8-K - Current report
15/08/202302:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/08/202320:30GLOBEPDS Biotech Reports Second Quarter 2023 Financial Results..
14/08/202320:00GLOBEPDS Biotech Announces Submission of Phase 3 Protocol to FDA..
07/08/202321:00GLOBEPDS Biotechnology Announces Conference Call and Webcast for..
02/08/202321:00GLOBEPDS Biotech to Present at BTIG Virtual Biotechnology..
26/07/202305:01EDGAR2Form 8-K - Current report
25/07/202321:00GLOBEPDS Biotech to Present Immune Response Data from Combination..
18/07/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/07/202306:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/07/202306:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/07/202306:24EDGAR2Form 8-K - Current report
18/07/202306:23EDGAR2Form 8-K - Current report
17/07/202321:00GLOBEPDS Biotech Announces Acceptance of Abstract on Combination..

최근 히스토리

Delayed Upgrade Clock